Abbott Laboratories stock forecast
Abbott Laboratories (ABT) Stock Forecast & Price Target
ABT Analyst Ratings
ABT Stock 12 Month Forecast
Average Price Target
CHF102.43▲(12.56% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Travis Steed | Bank of America Securities | CHF96.50→CHF104.89 | buy | 15.27%Upside | Reiterated | 11/09/26 | ||
| Adam Maeder | Piper Sandler | CHF99.02 | buy | 8.81%Upside | Reiterated | 11/02/26 | ||
| David Toung | Argus Research | ― | hold | ― | Downgraded | 10/26/26 | ||
| Larry Biegelsen | Wells Fargo | CHF99.86→CHF100.70 | buy | 10.66%Upside | Reiterated | 10/23/26 | ||
| Vijay Kumar | Evercore ISI | CHF104.05→CHF100.70 | buy | 10.66%Upside | Reiterated | 10/23/26 | ||
| Joanne Wuensch | Citi | CHF104.89→CHF102.37 | buy | 12.50%Upside | Assigned | 10/22/26 | ||
| Christopher Pasquale | Barclays | CHF100.70 | buy | 10.66%Upside | Reiterated | 10/22/26 | ||
| David Rescott | Robert W. Baird | CHF101.54→CHF103.21 | buy | 13.42%Upside | Reiterated | 10/22/26 | ||
| Josh Jennings | TD Cowen | CHF113.28→CHF99.02 | buy | 8.81%Upside | Assigned | 10/22/26 | ||
| Oppenheimer | CHF96.50 | buy | 6.04%Upside | Reiterated | 10/22/26 | |||
| Rick Wise | Stifel Nicolaus | CHF100.70 | buy | 10.66%Upside | Reiterated | 10/22/26 | ||
| Robbie Marcus | J.P. Morgan | CHF100.70→CHF99.02 | buy | 8.81%Upside | Reiterated | 10/22/26 | ||
| Marie Thibault | BTIG | CHF112.44→CHF104.89 | buy | 15.27%Upside | Reiterated | 10/21/26 | ||
| Kendall Au | RBC Capital | CHF109.09→CHF104.89 | buy | 15.27%Upside | Reiterated | 10/21/26 | ||
| Leerink Partners | ― | hold | ― | Reiterated | 10/12/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Travis SteedBank of America Securities | BuyReiteratedCHF96.50→CHF104.89 | 11/09/26 | 15.27%Upside | ||
| Adam MaederPiper Sandler | BuyReiteratedCHF99.02 | 11/02/26 | 8.81%Upside | ||
| David ToungArgus Research | HoldDowngraded | 10/26/26 | ― | ||
| Larry BiegelsenWells Fargo | BuyReiteratedCHF99.86→CHF100.70 | 10/23/26 | 10.66%Upside | ||
| Vijay KumarEvercore ISI | BuyReiteratedCHF104.05→CHF100.70 | 10/23/26 | 10.66%Upside | ||
| Joanne WuenschCiti | BuyAssignedCHF104.89→CHF102.37 | 10/22/26 | 12.50%Upside | ||
| Christopher PasqualeBarclays | BuyReiteratedCHF100.70 | 10/22/26 | 10.66%Upside | ||
| David RescottRobert W. Baird | BuyReiteratedCHF101.54→CHF103.21 | 10/22/26 | 13.42%Upside | ||
| Josh JenningsTD Cowen | BuyAssignedCHF113.28→CHF99.02 | 10/22/26 | 8.81%Upside | ||
| BuyReiteratedCHF96.50 | 10/22/26 | 6.04%Upside | |||
| Rick WiseStifel Nicolaus | BuyReiteratedCHF100.70 | 10/22/26 | 10.66%Upside | ||
| Robbie MarcusJ.P. Morgan | BuyReiteratedCHF100.70→CHF99.02 | 10/22/26 | 8.81%Upside | ||
| Marie ThibaultBTIG | BuyReiteratedCHF112.44→CHF104.89 | 10/21/26 | 15.27%Upside | ||
| Kendall AuRBC Capital | BuyReiteratedCHF109.09→CHF104.89 | 10/21/26 | 15.27%Upside | ||
| HoldReiterated | 10/12/26 | ― |
Best Analysts Covering Abbott Laboratories
Copying Matthew Taylor's trades and holding each position for 3 Months would result in 73.91% of your transactions generating a profit, with an average return of +3.06% per trade.
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 79.07% of your transactions generating a profit, with an average return of +14.90% per trade.
Copying Matthew Taylor's trades and holding each position for 2 Years would result in 73.91% of your transactions generating a profit, with an average return of +28.23% per trade.
ABT Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 33 | 42 | 36 | 38 | 27 |
| Hold | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 33 | 42 | 36 | 40 | 29 |
In the current month, ABT has received 27 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ABT average Analyst price target in the past 3 months is 102.43.
ABT Financial Forecast
ABT Earnings Forecast
Next quarter’s earnings estimate for ABT is CHF 1.37 with a range of CHF 1.36 to CHF 1.37. The previous quarter’s EPS was CHF 1.19. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ABT Sales Forecast
Next quarter’s sales forecast for ABT is CHF 11.03B with a range of CHF 10.98B to CHF 11.14B. The previous quarter’s sales results were CHF 10.87B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

